Hologic’s Unifi™ EQUIP Named "Best Overall MedTech Solution" in the 2020 MedTech Breakthrough Awards Program

May 20, 2020

Hologic’s Unifi™ EQUIP Named "Best Overall MedTech Solution" in

 the 2020 MedTech Breakthrough Awards Program

Innovative Platform Awarded Top Spot Among Hundreds of Submissions

 MARLBOROUGH, Mass. May 20, 2020 – Hologic, Inc. (Nasdaq: HOLX) announced today that Unifi™ EQUIP, an automated solution that facilitates compliance with the FDA’s Enhancing Quality Using the Inspection Program (EQUIP) guidance, was recognized as "Best Overall MedTech Solution" in the 2020 MedTech Breakthrough Awards program.

 MedTech Breakthrough is an independent organization that recognizes top companies and solutions in the global health and medical technology market. The awards program serves to find and recognize leaders in the most competitive categories of technology. 

 “We are thrilled to be recognized by MedTech Breakthrough in the Best Overall MedTech Solution category as it underscores our commitment to providing our customers and their patients with an integrated range of best-in-class solutions across the breast cancer continuum of care,” said Pete Valenti, Hologic’s Division President, Breast and Skeletal Health Solutions. “Unifi EQUIP continues to make a positive impact on our customers’ quality assurance efforts and is a key component in our mission to help healthcare providers deliver superior outcomes, at a lower cost, while delivering higher patient satisfaction.”

 The Unifi Enterprise platform is a comprehensive suite of software solutions that leverages data analytics to optimize the performance of capital equipment and reduce interruptions to patient care by laying a foundation for continued image quality improvement and corrective actions. Unifi™ Analytics is at the core of the platform, serving as a business intelligence tool for healthcare facilities that allows them to manage their mammography devices, monitor technologist performance, and prevent unanticipated downtime via a predictive tube replacement algorithm.

 “Since integrating Unifi EQUIP, our technologists and radiologists have experienced an increase in efficiency in managing, tracking and documenting our clients’ clinical images,” said Denise Hodges, Imaging Center Coordinator, Self Regional Healthcare. “In today’s healthcare landscape, facilities and clinicians are pressured to deliver a high quality of care while identifying cost savings and efficiencies. The entire Unifi Enterprise platform represents a comprehensive solution that allows us to operate efficiently while delivering the best possible care.”

 In 2019, Hologic launched Unifi EQUIP in partnership with MagView, a leading mammography information solutions provider. MagView offers solutions for breast imaging reporting, tracking, workflow and compliance, and is utilized by more than 2,500 facilities across the U.S., including many of the nation’s top cancer centers.

 About Hologic, Inc.

Hologic, Inc. is an innovative medical technology company primarily focused on improving women’s health and well-being through early detection and treatment. For more information on Hologic, visit www.hologic.com.

 Hologic, 3D Mammography and Unifi are trademarks and/or registered trademarks of Hologic, Inc., and/or its subsidiaries in the United States and/or other countries.

 Forward-Looking Statements

This news release may contain forward-looking information that involves risks and uncertainties, including statements about the use of Hologic products. There can be no assurance these products will achieve the benefits described herein or that such benefits will be replicated in any particular manner with respect to an individual patient, as the actual effect of the use of the products can only be determined on a case-by-case basis. In addition, there can be no assurance that these products will be commercially successful or achieve any expected level of sales. Hologic expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statements presented herein to reflect any change in expectations or any change in events, conditions or circumstances on which any such data or statements are based.

 This information is not intended as a product solicitation or promotion where such activities are prohibited. For specific information on what products are available for sale in a particular country, please contact a local Hologic sales representative or write to womenshealth@hologic.com.

 

Media Contact:

Jane Mazur

508.263.8764 (direct)

585.355.5978 (mobile)

jane.mazur@hologic.com

 

Investor Contact:

Michael Watts

858.410.8588

michael.watts@hologic.com